Vir Biotechnology (VIR) Interest & Investment Income (2018 - 2026)

Vir Biotechnology has disclosed Interest & Investment Income across 7 years of filings, most recently posting $7.2 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $7.2 million, down 41.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.1 million (down 44.06% YoY), and the FY2025 annual result was $40.2 million, down 43.97% from the prior year.
• Interest & Investment Income came in at $7.2 million for Q1 2026 at Vir Biotechnology, down from $7.8 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $21.9 million in Q3 2023 to a low of $7.2 million in Q1 2026.
• The 4-year median for Interest & Investment Income is $14.2 million (2024), against an average of $14.7 million.
• Across the five-year window, Interest & Investment Income dropped 20.08% in 2024 and slumped 46.58% in 2025, its largest moves.
• Vir Biotechnology's Interest & Investment Income stood at $20.7 million in 2023, then slumped by 31.75% to $14.2 million in 2024, then sank by 44.87% to $7.8 million in 2025, then slipped by 7.86% to $7.2 million in 2026.
• The last three Interest & Investment Income figures came in at $7.2 million (Q1 2026), $7.8 million (Q4 2025), and $9.4 million (Q3 2025), per Business Quant data.